TY - JOUR
T1 - Cytology interpretation after a change to HPV testing in primary cervical screening
T2 - Observational study from the English pilot
AU - for the HPV Pilot Steering Group
AU - Rebolj, Matejka
AU - Mathews, Christopher S.
AU - Denton, Karin
AU - Appleyard, Tracey Louise
AU - Cruickshank, Margaret
AU - Cuschieri, Kate
AU - Ellis, Kay
AU - Evans, Chris
AU - Frew, Viki
AU - Giles, Thomas
AU - Gray, Alastair
AU - Holbrook, Miles
AU - Hunt, Katherine
AU - Kitchener, Henry
AU - Levine, Tanya
AU - McBride, Emily
AU - Mesher, David
AU - Palmer, Timothy
AU - Parker, Janet
AU - Rimmer, Elizabeth
AU - Rudge Pickard, Hazel
AU - Sargent, Alexandra
AU - Smith, David
AU - Smith, John
AU - Soldan, Kate
AU - Stubbs, Ruth
AU - Tidy, John
AU - Tyler, Xenia
AU - Waller, Jo
N1 - Publisher Copyright:
© 2022 The Authors. Cancer Cytopathology published by Wiley Periodicals LLC on behalf of American Cancer Society.
PY - 2022/7
Y1 - 2022/7
N2 - BACKGROUND: Overcalling of abnormalities has been a concern for using cytology triage after positive high-risk human papillomavirus (HPV) tests in cervical screening. METHODS: The authors studied the detection of cytological and histological abnormalities at age 24 to 64 years, using data from the English HPV pilot. The pilot compared routine implementation of primary cervical screening based on cytology (N = 931,539), where HPV test results were not available before cytology reporting, with that based on HPV testing (N = 403,269), where cytology was only required after positive HPV tests. RESULTS: Revealed HPV positivity was associated with a higher direct referral to colposcopy after any abnormality (adjusted odds ratio [ORadj], 1.16; 95% confidence interval [CI], 1.14-1.18). Laboratories with higher direct referral referred fewer persistently HPV-positive women after early recall. The detection of high-grade cervical intraepithelial neoplasia (CIN2+) after direct referral increased with an ORadj of 1.17 (95% CI, 1.13-1.20) for informed versus uninformed cytology. Generally, the positive predictive value (PPV) of colposcopy for CIN2+ remained comparable under both conditions of interpreting cytology. In women 50 to 64 years old with high-grade dyskaryosis, however, the PPV increased from 71% to 83% after revealing HPV positivity (ORadj, 2.05; 95% CI, 1.43-2.93). CONCLUSIONS: Quality-controlled cervical screening programs can avoid inappropriate overgrading of HPV-positive cytology.;.
AB - BACKGROUND: Overcalling of abnormalities has been a concern for using cytology triage after positive high-risk human papillomavirus (HPV) tests in cervical screening. METHODS: The authors studied the detection of cytological and histological abnormalities at age 24 to 64 years, using data from the English HPV pilot. The pilot compared routine implementation of primary cervical screening based on cytology (N = 931,539), where HPV test results were not available before cytology reporting, with that based on HPV testing (N = 403,269), where cytology was only required after positive HPV tests. RESULTS: Revealed HPV positivity was associated with a higher direct referral to colposcopy after any abnormality (adjusted odds ratio [ORadj], 1.16; 95% confidence interval [CI], 1.14-1.18). Laboratories with higher direct referral referred fewer persistently HPV-positive women after early recall. The detection of high-grade cervical intraepithelial neoplasia (CIN2+) after direct referral increased with an ORadj of 1.17 (95% CI, 1.13-1.20) for informed versus uninformed cytology. Generally, the positive predictive value (PPV) of colposcopy for CIN2+ remained comparable under both conditions of interpreting cytology. In women 50 to 64 years old with high-grade dyskaryosis, however, the PPV increased from 71% to 83% after revealing HPV positivity (ORadj, 2.05; 95% CI, 1.43-2.93). CONCLUSIONS: Quality-controlled cervical screening programs can avoid inappropriate overgrading of HPV-positive cytology.;.
KW - cytology
KW - mass screening
KW - papillomavirus infections
KW - uterine cervical neoplasms
UR - http://www.scopus.com/inward/record.url?scp=85127598420&partnerID=8YFLogxK
U2 - 10.1002/cncy.22572
DO - 10.1002/cncy.22572
M3 - Article
C2 - 35377967
AN - SCOPUS:85127598420
SN - 1934-662X
VL - 130
SP - 531
EP - 541
JO - Cancer Cytopathology
JF - Cancer Cytopathology
IS - 7
ER -